The US Food and Drug Administration (FDA) has granted breakthrough designation for SyncThink's Eye-Sync technology, a virtual reality eye-tracking platform that provides objective measurements to aid ...
SyncThink, a Boston-based applying VR and eye-tracking to assess ability to focus as an indicator of concussion damage, has launched the next generation of its FDA-cleared EYE-SYNC platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results